ELEKTA, INC.

Lobbying for ELEKTA, INC.

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Jun 29, 2026

Expenses

$70,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Government bodies contacted 7

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 8

Budget/Appropriations

CY2027 Appropriations

Energy/Nuclear

Gamma Knife/Cobalt-60

Health Issues

Radiation Oncology, Oncology, other Cancer Care related issues

Medical/Disease Research/Clinical Labs

Medical Device, Clinical trials

Accounting

N/A

Medicare/Medicaid